Comparing Effectiveness of Three Different Anti-VEGF Treatment Regimens for Neovascular Age-Related Macular Degeneration: Two Years’ Real-World Clinical Outcomes

PURPOSE: To compare and report the 2-year treatment outcomes from 3 different anti-VEGF treatment regimens in treating neovascular aged-related macular degeneration (nAMD): Ranibizumab pro re nata (Ranibizumab-PRN); Ranibizumab treat and extend (Ranibizumab-T&E); Aflibercept fixed first year dos...

Descripción completa

Detalles Bibliográficos
Autores principales: Horner, Faye, Lip, Peck Lin, Mohammed, Bashar R, Fusi-Rubiano, William, Gokhale, Eesha, Mushtaq, Bushra, Chavan, Randhir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080302/
https://www.ncbi.nlm.nih.gov/pubmed/33935487
http://dx.doi.org/10.2147/OPTH.S305141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080302/
https://www.ncbi.nlm.nih.gov/pubmed/33935487
http://dx.doi.org/10.2147/OPTH.S305141

Ejemplares similares